266 related articles for article (PubMed ID: 21051559)
1. Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.
Eisenhofer G; Pacak K; Huynh TT; Qin N; Bratslavsky G; Linehan WM; Mannelli M; Friberg P; Grebe SK; Timmers HJ; Bornstein SR; Lenders JW
Endocr Relat Cancer; 2011 Feb; 18(1):97-111. PubMed ID: 21051559
[TBL] [Abstract][Full Text] [Related]
2. Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
Huynh TT; Pacak K; Brouwers FM; Abu-Asab MS; Worrell RA; Walther MM; Elkahloun AG; Goldstein DS; Cleary S; Eisenhofer G
Eur J Endocrinol; 2005 Oct; 153(4):551-63. PubMed ID: 16189177
[TBL] [Abstract][Full Text] [Related]
3. Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location.
Eisenhofer G; Timmers HJ; Lenders JW; Bornstein SR; Tiebel O; Mannelli M; King KS; Vocke CD; Linehan WM; Bratslavsky G; Pacak K
J Clin Endocrinol Metab; 2011 Feb; 96(2):375-84. PubMed ID: 21147885
[TBL] [Abstract][Full Text] [Related]
4. Urinary free (unconjugated) metadrenalines in different hereditary forms of catecholamine-secreting phaeochromocytoma/paraganglioma.
Davidson DF; Bradshaw N; Perry CG; Lindsay R; Freel EM
Ann Clin Biochem; 2012 Sep; 49(Pt 5):486-90. PubMed ID: 22914444
[TBL] [Abstract][Full Text] [Related]
5. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
[TBL] [Abstract][Full Text] [Related]
6. Chromogranin a expression in phaeochromocytomas associated with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
Cleary S; Phillips JK; Huynh TT; Pacak K; Fliedner S; Elkahloun AG; Munson P; Worrell RA; Eisenhofer G
Horm Metab Res; 2007 Dec; 39(12):876-83. PubMed ID: 18046660
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma.
Eisenhofer G; Huynh TT; Elkahloun A; Morris JC; Bratslavsky G; Linehan WM; Zhuang Z; Balgley BM; Lee CS; Mannelli M; Lenders JW; Bornstein SR; Pacak K
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1223-33. PubMed ID: 18854424
[TBL] [Abstract][Full Text] [Related]
8. Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours.
Srirangalingam U; Khoo B; Walker L; MacDonald F; Skelly RH; George E; Spooner D; Johnston LB; Monson JP; Grossman AB; Drake WM; Akker SA; Pollard PJ; Plowman N; Avril N; Berney DM; Burrin JM; Reznek RH; Kumar VK; Maher ER; Chew SL
Endocr Relat Cancer; 2009 Jun; 16(2):515-25. PubMed ID: 19208735
[TBL] [Abstract][Full Text] [Related]
9. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.
Eisenhofer G; Lenders JW; Timmers H; Mannelli M; Grebe SK; Hofbauer LC; Bornstein SR; Tiebel O; Adams K; Bratslavsky G; Linehan WM; Pacak K
Clin Chem; 2011 Mar; 57(3):411-20. PubMed ID: 21262951
[TBL] [Abstract][Full Text] [Related]
10. Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.
Eisenhofer G; Walther MM; Huynh TT; Li ST; Bornstein SR; Vortmeyer A; Mannelli M; Goldstein DS; Linehan WM; Lenders JW; Pacak K
J Clin Endocrinol Metab; 2001 May; 86(5):1999-2008. PubMed ID: 11344198
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y expression in phaeochromocytomas: relative absence in tumours from patients with von Hippel-Lindau syndrome.
Cleary S; Phillips JK; Huynh TT; Pacak K; Elkahloun AG; Barb J; Worrell RA; Goldstein DS; Eisenhofer G
J Endocrinol; 2007 May; 193(2):225-33. PubMed ID: 17470513
[TBL] [Abstract][Full Text] [Related]
12. Subclinical phaeochromocytoma.
Mannelli M; Lenders JW; Pacak K; Parenti G; Eisenhofer G
Best Pract Res Clin Endocrinol Metab; 2012 Aug; 26(4):507-15. PubMed ID: 22863392
[TBL] [Abstract][Full Text] [Related]
13. Lack of utility of SDHB mutation testing in adrenergic metastatic phaeochromocytoma.
Sue M; Martucci V; Frey F; Lenders JM; Timmers HJ; Peczkowska M; Prejbisz A; Swantje B; Bornstein SR; Arlt W; Fassnacht M; Beuschlein F; Robledo M; Pacak K; Eisenhofer G
Eur J Endocrinol; 2015 Feb; 172(2):89-95. PubMed ID: 25371406
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
van Nederveen FH; Gaal J; Favier J; Korpershoek E; Oldenburg RA; de Bruyn EM; Sleddens HF; Derkx P; Rivière J; Dannenberg H; Petri BJ; Komminoth P; Pacak K; Hop WC; Pollard PJ; Mannelli M; Bayley JP; Perren A; Niemann S; Verhofstad AA; de Bruïne AP; Maher ER; Tissier F; Méatchi T; Badoual C; Bertherat J; Amar L; Alataki D; Van Marck E; Ferrau F; François J; de Herder WW; Peeters MP; van Linge A; Lenders JW; Gimenez-Roqueplo AP; de Krijger RR; Dinjens WN
Lancet Oncol; 2009 Aug; 10(8):764-71. PubMed ID: 19576851
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Subtyping of Pheochromocytoma and Paraganglioma by
van Berkel A; Vriens D; Visser EP; Janssen MJR; Gotthardt M; Hermus ARMM; Geus-Oei LF; Timmers HJLM
J Nucl Med; 2019 Jun; 60(6):745-751. PubMed ID: 30413658
[TBL] [Abstract][Full Text] [Related]
16. No correlation between phaeochromocytoma catecholamine secretion and granule ultrastructure.
Mihai R; Wong NA; Luckett M; Sheffield E; Farndon JR
Br J Surg; 1998 Dec; 85(12):1681-5. PubMed ID: 9876074
[TBL] [Abstract][Full Text] [Related]
17. Pheochromocytoma: rediscovery as a catecholamine-metabolizing tumor.
Eisenhofer G; Goldstein DS; Kopin IJ; Crout JR
Endocr Pathol; 2003; 14(3):193-212. PubMed ID: 14586065
[TBL] [Abstract][Full Text] [Related]
18. Significance of Alpha-inhibin Expression in Pheochromocytomas and Paragangliomas.
Mete O; Pakbaz S; Lerario AM; Giordano TJ; Asa SL
Am J Surg Pathol; 2021 Sep; 45(9):1264-1273. PubMed ID: 33826547
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of laboratory data of 155 patients with pheochromocytoma-paraganglioma syndrome diagnosed during the past 20 years].
Balog B; Tőke J; Róna K; Szücs N; Igaz P; Pusztai P; Sármán B; Gláz E; Kiss R; Patócs A; Rácz K; Tóth M
Orv Hetil; 2015 Apr; 156(16):626-35. PubMed ID: 25864138
[TBL] [Abstract][Full Text] [Related]
20. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
